Investigating the validity of the Strengths and Difficulties Questionnaire to assess ADHD in young adulthood.


Journal

Psychiatry research
ISSN: 1872-7123
Titre abrégé: Psychiatry Res
Pays: Ireland
ID NLM: 7911385

Informations de publication

Date de publication:
07 2021
Historique:
received: 12 01 2021
accepted: 26 04 2021
pubmed: 16 5 2021
medline: 15 10 2021
entrez: 15 5 2021
Statut: ppublish

Résumé

Attention Deficit Hyperactivity Disorder (ADHD) symptoms typically onset early and persist into adulthood for many. Robust investigation of symptom continuity and discontinuity requires repeated assessments using the same measure, but research is lacking into whether measures used to assess ADHD symptoms in childhood are also valid in adulthood. The Strengths and Difficulties Questionnaire (SDQ) is widely used to assess ADHD symptoms in children, but little is known about its utility in adulthood. The aim of this study was to assess the validity of the SDQ hyperactivity/ADHD subscale to distinguish between cases and non-cases of DSM-5 ADHD at age 25 years in a UK population cohort (N = 4121). ADHD diagnosis was derived using the Barkley Adult ADHD Rating Scale-IV. Analyses suggested that the self-rated SDQ ADHD subscale had high validity in distinguishing ADHD cases/non-cases in young adulthood (area under the curve=0.90, 95% CI=0.87-0.93) and indicated a lower cut-point for identifying those who may have an ADHD diagnosis in this age group compared to that currently recommended for younger ages. Findings were similar for parent-reports. Our findings suggest that the SDQ is suitable for ADHD research across different developmental periods, which will aid the robust investigation of ADHD from childhood to young adulthood.

Identifiants

pubmed: 33991992
pii: S0165-1781(21)00281-X
doi: 10.1016/j.psychres.2021.113984
pmc: PMC9227718
pii:
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

113984

Subventions

Organisme : Wellcome Trust
ID : 217065/Z/19/Z
Pays : United Kingdom
Organisme : Medical Research Council
ID : MC_PC_19009
Pays : United Kingdom
Organisme : Medical Research Council
ID : MC_PC_15018
Pays : United Kingdom
Organisme : Medical Research Council
ID : G9815508
Pays : United Kingdom
Organisme : Wellcome Trust
Pays : United Kingdom
Organisme : Medical Research Council
ID : MC_UU_00011/3
Pays : United Kingdom
Organisme : HCRW_
ID : HCRW_NIHR-FS-PD-2018
Pays : United Kingdom
Organisme : Medical Research Council
ID : MC_UU_00011/1
Pays : United Kingdom
Organisme : Department of Health
Pays : United Kingdom
Organisme : Wellcome Trust
ID : 204895/Z/16/Z
Pays : United Kingdom

Informations de copyright

Copyright © 2021. Published by Elsevier B.V.

Références

Cancer. 1950 Jan;3(1):32-5
pubmed: 15405679
Br J Psychiatry. 2000 Dec;177:534-9
pubmed: 11102329
Psychol Med. 2006 Feb;36(2):159-65
pubmed: 16420712
J Atten Disord. 2012 Jul;16(5 Suppl):20S-38S
pubmed: 22377849
J Am Acad Child Adolesc Psychiatry. 2001 Nov;40(11):1337-45
pubmed: 11699809
Wellcome Open Res. 2019 Mar 14;4:51
pubmed: 31020050
Neuropsychopharmacology. 2020 Sep;45(10):1617-1626
pubmed: 32279069
Epidemiol Psychiatr Sci. 2019 May 15;29:e37
pubmed: 31088588
Int J Epidemiol. 2018 Aug 1;47(4):1207-1216
pubmed: 29800128
Front Psychol. 2015 Jun 10;6:811
pubmed: 26113840
Psychol Med. 2014 Jul;44(10):2223-9
pubmed: 24107258
Epidemiol Psychiatr Sci. 2020 Jan 09;29:e87
pubmed: 31915090
J Abnorm Psychol. 2012 Nov;121(4):991-1010
pubmed: 22612200
J Abnorm Child Psychol. 2013 May;41(4):583-95
pubmed: 23183936
Int J Epidemiol. 2013 Feb;42(1):111-27
pubmed: 22507743
J Abnorm Psychol. 2002 May;111(2):279-89
pubmed: 12003449
Int Rev Psychiatry. 2003 Feb-May;15(1-2):173-7
pubmed: 12745329
Am J Epidemiol. 2016 Jun 15;183(12):1149-58
pubmed: 27188935
Int J Epidemiol. 2013 Feb;42(1):97-110
pubmed: 22507742
J Atten Disord. 2008 May;11(6):628-41
pubmed: 18094324
Lancet. 2016 Mar 19;387(10024):1240-50
pubmed: 26386541
J Child Psychol Psychiatry. 1997 Jul;38(5):581-6
pubmed: 9255702
Br J Psychiatry. 2009 Mar;194(3):204-11
pubmed: 19252145
Soc Psychiatry Psychiatr Epidemiol. 2007 Apr;42(4):322-7
pubmed: 17334898
Science. 1988 Jun 3;240(4857):1285-93
pubmed: 3287615
J Child Psychol Psychiatry. 2021 Apr;62(4):449-457
pubmed: 32663329
Am J Psychiatry. 2006 Apr;163(4):716-23
pubmed: 16585449
Psychiatry Res. 2018 Jun;264:340-345
pubmed: 29674224
Eur Child Adolesc Psychiatry. 2016 Sep;25(9):949-57
pubmed: 26762184

Auteurs

Lucy Riglin (L)

Division of Psychological Medicine and Clinical Neurosciences, MRC Centre for Neuropsychiatric Genetics and Genomics, Cardiff University, Wales, United Kingdom.

Sharifah Shameem Agha (SS)

Division of Psychological Medicine and Clinical Neurosciences, MRC Centre for Neuropsychiatric Genetics and Genomics, Cardiff University, Wales, United Kingdom; Cwm Taf Morgannwg University Health Board, Wales, United Kingdom.

Olga Eyre (O)

Division of Psychological Medicine and Clinical Neurosciences, MRC Centre for Neuropsychiatric Genetics and Genomics, Cardiff University, Wales, United Kingdom.

Rhys Bevan Jones (R)

Division of Psychological Medicine and Clinical Neurosciences, MRC Centre for Neuropsychiatric Genetics and Genomics, Cardiff University, Wales, United Kingdom; Cwm Taf Morgannwg University Health Board, Wales, United Kingdom.

Robyn E Wootton (RE)

MRC Integrative Epidemiology Unit, University of Bristol, Bristol, United Kingdom; Nic Waals Institute, Lovisenberg Diaconal Hospital, Oslo, Norway.

Ajay K Thapar (AK)

Division of Psychological Medicine and Clinical Neurosciences, MRC Centre for Neuropsychiatric Genetics and Genomics, Cardiff University, Wales, United Kingdom.

Stephan Collishaw (S)

Division of Psychological Medicine and Clinical Neurosciences, MRC Centre for Neuropsychiatric Genetics and Genomics, Cardiff University, Wales, United Kingdom.

Evie Stergiakouli (E)

MRC Integrative Epidemiology Unit, University of Bristol, Bristol, United Kingdom; Population Health Sciences, Bristol Medical School, University of Bristol, Bristol, United Kingdom.

Kate Langley (K)

Division of Psychological Medicine and Clinical Neurosciences, MRC Centre for Neuropsychiatric Genetics and Genomics, Cardiff University, Wales, United Kingdom; School of Psychology, Cardiff University, Wales, United Kingdom.

Anita Thapar (A)

Division of Psychological Medicine and Clinical Neurosciences, MRC Centre for Neuropsychiatric Genetics and Genomics, Cardiff University, Wales, United Kingdom. Electronic address: Thapar@Cardiff.ac.uk.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH